Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal stromal cells for steroid-refractory chronic graft-versus-host disease after allogeneic stem cell transplantation
RBR-7s99ksfPhase 2Terminated
- Sponsor
- Hospital de Clínicas da Universidade Federal do Paraná
- Start
- Apr 2015
- Modality
- Mesenchymal Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Provacel in chronic graft-versus-host disease (cGVHD) and graft-versus-host disease (GVHD), sponsored by Hospital de Clínicas da Universidade Federal do Paraná. Started Apr 2015; status: terminated.
02
Drugs
Provacel
03
Conditions
chronic graft-versus-host disease (cGVHD)graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on RBR-7s99ksf.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7s99ksf.